Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carmell Therapeutics (CTCX)
NASDAQ:CTCX
Holding CTCX?
Track your performance easily
Carmell Therapeutics (CTCX) Ownership Overview
23.61% Insiders
1.24% Mutual Funds
10.92% Other Institutional Investors
1.00% ETFs
63.23% Public Companies and
Individual Investors
The ownership structure of Carmell Therapeutics (CTCX) stock is a mix of institutional, retail, and individual investors. Approximately 13.16% of the company’s stock is owned by Institutional Investors, 23.61% is owned by Insiders, and 63.23% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 16, 2024 | Richard A Upton Director | xxxxxxxxxxxxx | $2300 |
| Sep 10, 2024 | Kathryn Gregory Director | xxxxxxxxxxxxx | $643 |
| Sep 10, 2024 | Scott M. Frisch Director | xxxxxxxxxxxxx | $515 |
| Sep 10, 2024 | xxxxxxxxxxxxx | $219 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,328,653 | Insider | 15.92% | 815,520 | |
| 1,373,019 | Insider | 6.57% | 336,390 | |
| 179,591 | Institution | 0.86% | 44,000 | |
| 179,591 | Institution | 0.86% | 44,000 | |
| 115,089 | Insider | 0.55% | 28,197 | |
| 79,130 | Institution | 0.38% | 19,387 | |
| 77,632 | Insider | 0.37% | 19,020 | |
| 29,596 | Institution | 0.14% | 7,251 | |
| 22,500 | Insider | 0.11% | 5,513 | |
| 7,598 | Insider | 0.04% | 1,862 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 179,591 | Institution | 0.86% | 44,000 | |
| 79,130 | Institution | 0.38% | 19,387 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 168,369 | Institution | 0.81% | 55,932 | |
| 29,596 | Institution | 0.14% | 7,266 | |
| 11,222 | Institution | 0.05% | 3,728 |
FAQ
Who Owns Carmell Therapeutics (CTCX)?
According to the latest TipRanks data, approximately 10.92% of the company's stock is held by institutional investors, 23.61% is held by insiders, and 63.23% is held by retail investors.
What percentage of Carmell Therapeutics (CTCX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.92% of Carmell Therapeutics (CTCX) stock is held by institutional investors.
What percentage of Carmell Therapeutics (CTCX) stock is held by retail investors?
According to the latest TipRanks data, approximately 63.23% of Carmell Therapeutics (CTCX) stock is held by retail investors.
Who owns the most shares of Carmell Therapeutics (CTCX)?
Rajiv Shukla owns the most shares of Carmell Therapeutics (CTCX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.